Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 26 clinical trials
Nemvaleukin Alfa (ALKS 4230) Monotherapy in Patients With Advanced Cutaneous Melanoma or Advanced Mucosal Melanoma - ARTISTRY-6 (ARTISTRY-6)

This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma following prior anti-PD-[L]-1 therapy

BRAF
malignant melanoma of skin
immunologic adjuvant
metastatic melanoma
targeted therapy
  • 0 views
  • 18 May, 2022
  • 12 locations
A Phase 1 Study of SGN-CD228A in Select Advanced Solid Tumors

This trial will study SGN-CD228A to find out whether it is an effective treatment for different kinds of cancer. It will also look at what side effects (unwanted effects) may occur. The study will have two parts. Part 1 of the study will find out how much SGN-CD228A should be …

lung carcinoma
progressive disease
malignant melanoma of skin
erbb2
lung cancer
  • 16 views
  • 19 Sep, 2022
  • 14 locations
An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination With PD1 Blockade in Patients With Solid Tumors (IGNYTE)

RPL-001-16 is a Phase 1/2, open label, dose escalation and expansion clinical study of RP1 alone and in combination with nivolumab in adult subjects with advanced and/or refractory solid tumors, to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), as well as to evaluate preliminary efficacy.

bladder cancer
BRAF
progressive disease
solid neoplasm
malignant melanoma of skin
  • 127 views
  • 20 Sep, 2022
  • 46 locations
A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects With Advanced Malignancies

This trial will look at a drug called SEA-TGT (also known as SGN-TGT) to find out whether it is safe for patients with solid tumors and lymphomas. It will study SEA-TGT to find out what its side effects are. A side effect is anything the drug does besides treating cancer. …

progressive disease
diffuse large b-cell lymphoma
combination chemotherapy
erbb2
b-cell lymphoma
  • 110 views
  • 21 Sep, 2022
  • 33 locations
MoleGazer Development Feasibility Study

Melanoma (skin cancer) frequently develops from existing moles on the skin. Current practice relies on expert dermatologists being able to successfully identify new/changing moles in individuals with multiple moles. Total body photography (TBP-high-quality images of the entire skin) can track and monitor moles over time to detect melanoma. However, TBP …

cancer
skin cancer screening
  • 0 views
  • 30 Sep, 2021
  • 1 location
Irradiation of Melanoma in a Pulse

This is a single center phase I, first-in-human, dose escalation study of FLASH therapy in patients with metastases of melanoma. The trial is based on escalating single doses of FLASH therapy administered to skin melanoma metastases using the Mobetron with high dose rate (HDR) functionality. The aim of the study …

  • 0 views
  • 05 Sep, 2021
  • 1 location
Neoadjuvant Atezolizumab in Cutaneous Melanoma

The purpose of this research study is to see whether using atezolizumab before surgery is safe and does not cause side effects that delay surgery in participants with cutaneous melanoma that has not spread to other areas of the body (non-metastatic) and can be removed by surgery (resectable) but has …

cancer
malignant melanoma of skin
  • 0 views
  • 21 Mar, 2022
  • 1 location
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

This is a pilot study of combination low dose rate brachytherapy (LDR) added to standard of care (SOC) immunotherapy with Nivolumab in stage III and IV melanoma.

  • 0 views
  • 12 Aug, 2022
  • 1 location
Neoadjuvant Combination Immunotherapy for Stage III Melanoma

Determine safety and efficacy of pre-operative combination immunotherapy with Talimogene Laherparepvec (T-VEC)/Pembrolizumab given prior to complete lymph node dissection in resectable stage 3 cutaneous melanoma with clinically apparent lymph node metastases.

BRAF
malignant melanoma of skin
stage iii melanoma
measurable disease
pembrolizumab
  • 0 views
  • 21 Jul, 2022
  • 1 location
Exercise to Boost Response to Checkpoint Blockade Immunotherapy

30 minutes of moderate exercise on an arm ergometer, a cycle ergometer, or a treadmill prior to each administration of standard of care checkpoint blockade immunotherapy across all cycles

immunologic adjuvant
vaccination
targeted therapy
carcinoma
pembrolizumab
  • 0 views
  • 23 May, 2022
  • 1 location